Global Travel Vaccines Market Strategies 2024, Forecast To 2033
8 Mar, 2024
The travel vaccines market has seen strong growth, rising from $4.41 billion in 2023 to $4.79 billion in 2024, with a CAGR of 8.7%. This growth is attributed to factors such as increased international travel and government initiatives for travel health. Forecasts suggest continued strong growth, with the market expected to reach $6.79 billion in 2028, boasting a CAGR of 9.1%. Key drivers include increasing frequency of business travel and collaboration between governments and pharmaceutical companies. Major trends include tailored vaccination strategies and adoption of digital health technologies.
Global Travel Vaccines Market Key Driver
The travel vaccine market is growing due to the increase in travel and tourism. Travel vaccines are essential for keeping travelers safe and healthy. The United Nations World Tourism Organization reports a significant surge in international tourist arrivals, indicating a strong market driver for travel vaccines.
Get A Free Sample Of The Global Travel Vaccines Market ReportGlobal Travel Vaccines Market Segments
The travel vaccines market covered in this report is segmented –
1) Disease:Hepatitis A, Diphtheria, Pertussis, And Tetanus (DPT), Yellow Fever, Typhoid, Hepatitis B, Measles And Mumps, Rabies, Meningococcal, Other Diseases,
2) Composition:Mono Vaccines, Combination Vaccines
3) Booking Channel:Online Booking, In-Person Booking
4) Application:Domestic Travel, Outbound Travel
By Geography: The countries covered in the travel vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
North America was the largest region in the travel vaccines market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the travel vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Major Travel Vaccines Industry Players
Pfizer Inc.; Johnson and Johnson; Merck & Co. Inc.; Novartis AG; Sanofi SA; AstraZeneca PLC.; GlaxoSmithKline plc; Moderna Inc.; BioNTech Europe GmbH; Biological E. Limited; Bausch Health Companies Inc.; Takeda Pharmaceutical Company Limited; Novavax Inc.; Emergent BioSolutions UK; Serum Institute of India Pvt. Ltd.; Dynavax Technologies; Bavarian Nordic A/S; Valneva SE; Panacea Biotec; Vabiotech; Inovio Pharmaceuticals; Bharat Biotech International Limited; Altimmune Inc.; Bio Farma; Vaxart Inc.
Get The Full Global Travel Vaccines Market Report
Travel Vaccines Market Overview
Travel vaccines are vaccines to protect against diseases that are either indigenous to the country of origin or the country of destination. They function to safeguard travelers and stop the spread of disease both within and between nations.